Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Expert Opinion on Therapeutic Targets|August 18, 2018
Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancerDaniela Loessner, Peter Goettig, Sarah Preis, et al.
Biological Chemistry|July 17, 2008
Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7Mekdes Debela, Nathalie Beaufort, Viktor Magdolen, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 7, 2003
Inhibition of the tumor-associated urokinase-type plasminogen activation system: effects of high-level synthesis of soluble urokinase receptor in ovarian and breast cancer cells in vitro and in vivoViktor Magdolen, Achim Krüger, Sumito Sato, et al.
The Journal of Biological Chemistry|October 19, 2014
Structure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activityWolfgang Skala, Daniel T Utzschneider, Viktor Magdolen, et al.
Journal of Molecular Biology|September 5, 2006
Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding siteMekdes Debela, Viktor Magdolen, Valerie Grimminger, et al.
The Journal of Biological Chemistry|June 3, 2006
Specificity profiling of seven human tissue kallikreins reveals individual subsite preferencesMekdes Debela, Viktor Magdolen, Norman Schechter, et al.
Biological Chemistry|August 26, 2014
Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancerFrancine Walker, Pascal Nicole, Abdelhak Jallane, et al.
Pageof 13